BACKGROUND: Soft tissue sarcomas (STS) are relatively uncommon tumors. Data regarding the patterns of care of patients with STS and its consistency with available guidelines are relatively sparse. The authors conducted a detailed analysis of STS patients diagnosed in 2002 and sampled from the Surveillance, Epidemiology, and End Results registries. METHODS: The authors sampled 1369 patients with invasive sarcomas. Hospital records were reabstracted, and treating physicians were contacted to verify the therapy provided to each patient. RESULTS: The median age of patients was 60 years. There was a slight male predominance among the patients with nongynecologic sarcomas. Fifty percent of the patients had localized stage sarcoma. Most patients received surgery, but negative margins were obtained in only 50% of patients. Complete resection was less frequent in patients >or=50 years old. Radiation therapy was used in 53% of patients with extremity sarcomas but in only 20% to 30% of the patients with sarcomas at other sites. About 27% of all patients received chemotherapy. Tumor grade was significantly associated with the use of radiation and chemotherapy. Surgical resection, tumor grade, tumor size, use of radiation therapy, and age significantly influenced survival. CONCLUSIONS: Patterns of care of STS differ based on the site of the tumor. The patterns of care for extremity sarcomas are fairly consistent with the available recommendations, but the patterns of care for other sites are less consistent. In addition to certain tumor characteristics, age of the patient was significantly associated with therapy and patient outcome. (c) 2009 American Cancer Society.
BACKGROUND: Soft tissue sarcomas (STS) are relatively uncommon tumors. Data regarding the patterns of care of patients with STS and its consistency with available guidelines are relatively sparse. The authors conducted a detailed analysis of STS patients diagnosed in 2002 and sampled from the Surveillance, Epidemiology, and End Results registries. METHODS: The authors sampled 1369 patients with invasive sarcomas. Hospital records were reabstracted, and treating physicians were contacted to verify the therapy provided to each patient. RESULTS: The median age of patients was 60 years. There was a slight male predominance among the patients with nongynecologic sarcomas. Fifty percent of the patients had localized stage sarcoma. Most patients received surgery, but negative margins were obtained in only 50% of patients. Complete resection was less frequent in patients >or=50 years old. Radiation therapy was used in 53% of patients with extremity sarcomas but in only 20% to 30% of the patients with sarcomas at other sites. About 27% of all patients received chemotherapy. Tumor grade was significantly associated with the use of radiation and chemotherapy. Surgical resection, tumor grade, tumor size, use of radiation therapy, and age significantly influenced survival. CONCLUSIONS: Patterns of care of STS differ based on the site of the tumor. The patterns of care for extremity sarcomas are fairly consistent with the available recommendations, but the patterns of care for other sites are less consistent. In addition to certain tumor characteristics, age of the patient was significantly associated with therapy and patient outcome. (c) 2009 American Cancer Society.
Authors: Julia J Jones; Charles N Catton; Brian O'Sullivan; Jean Couture; Ryan L Heisler; Rita A Kandel; Carol J Swallow Journal: Ann Surg Oncol Date: 2002-05 Impact factor: 5.344
Authors: Emad Youssef; James Fontanesi; Michael Mott; Michael Kraut; David Lucas; Hany Mekhael; Edgar Ben-Josef Journal: Int J Radiat Oncol Biol Phys Date: 2002-10-01 Impact factor: 7.038
Authors: C N Catton; B O'Sullivan; C Kotwall; B Cummings; Y Hao; V Fornasier Journal: Int J Radiat Oncol Biol Phys Date: 1994-07-30 Impact factor: 7.038
Authors: I Ray-Coquard; P Thiesse; D Ranchère-Vince; F Chauvin; J-Y Bobin; M-P Sunyach; J-P Carret; B Mongodin; P Marec-Bérard; T Philip; J-Y Blay Journal: Ann Oncol Date: 2004-02 Impact factor: 32.976
Authors: L Livi; F Paiar; N Shah; P Blake; A Villanucci; G Amunni; R Barca; I Judson; N Lodge; E Meldolesi; G Simontacchi; G Piperno; A Galardi; S Scoccianti; G P Biti; C Harmer Journal: Int J Radiat Oncol Biol Phys Date: 2003-12-01 Impact factor: 7.038
Authors: Maria Anna Smolle; Dimosthenis Andreou; Per-Ulf Tunn; Joanna Szkandera; Bernadette Liegl-Atzwanger; Andreas Leithner Journal: EFORT Open Rev Date: 2017-10-17
Authors: Michele M Gage; Neeraja Nagarajan; Jessica M Ruck; Joseph K Canner; Salma Khan; Katherine Giuliano; Faiz Gani; Christopher Wolfgang; Fabian M Johnston; Nita Ahuja Journal: Oncotarget Date: 2019-03-29
Authors: Johannes Zeller; Jurij Kiefer; David Braig; Oscar Winninger; David Dovi-Akue; Georg W Herget; G B Stark; Steffen U Eisenhardt Journal: Front Oncol Date: 2019-11-26 Impact factor: 6.244
Authors: Herbert Ho-Fung Loong; Carlos King Ho Wong; Yihui Wei; Sampson Sui Chun Kwan; Yingjun Zhang; Teresa Tse; Yat-Ming Lau; Linda K S Leung; Gordon C H Tang Journal: ESMO Open Date: 2020-11